cardiovascular disease

by American Heart Association edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Driven by rising rates in high blood pressure, nearly 6 in 10 women in the U.S. will have some type of cardiovascular disease (CVD) in the next 25 years, according to a new scientific […]

Sara Novak Doctors have long looked at certain risk factors including blood pressure, cholesterol, diabetes, smoking, and family history to predict a patient’s risk for cardiovascular disease. But increasingly, another lesser known biomarker, known as high-sensitivity C-reactive protein (hsCRP), seems to play an important role in whether a patient is at risk for a heart

by American Heart Association edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes Credit: Unsplash/CC0 Public Domain In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent

by Ludwig Maximilian University of Munich edited by Gaby Clark, reviewed by Robert Egan   Credit: Pixabay/CC0 Public Domain Lowering the activity of interleukin-6 (IL-6)—a key immune signal regulating inflammatory responses in the body—could reduce the risk of cardiovascular disease without making people more vulnerable to infections, according to new research from LMU’s Institute for Stroke and Dementia